Antonio R Pera
CIK 1689325 · President, Par Pharmaceutical · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.21M
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$1.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 27,017 | $81.68 | $2.21M | -$1.69M | 12 | 2026-06-10 |
| Endo International plc (ENDP) Delisted | President, Par Pharmaceutical | 65,648 | $0.29 | $19.2K | $0 | 13 | 2019-04-04 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-22 | Endo International plc (ENDP) Delisted | Tax (F) | −3,117 | -$20.9K | EDGAR |
| 2017-10-02 | Endo International plc (ENDP) Delisted | Tax (F) | −135 | -$1.1K | EDGAR |
| 2017-08-11 | Endo International plc (ENDP) Delisted | Grant (A) | +47,916 | $0 | EDGAR |
| 2017-02-27 | Endo International plc (ENDP) Delisted | Tax (F) | −247 | -$3.3K | EDGAR |
| 2017-02-23 | Endo International plc (ENDP) Delisted | Grant (A) | +23,249 | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.